San Anselmo María, Lantero Elena, Avalos-Padilla Yunuen, Bouzón-Arnáiz Inés, Ramírez Miriam, Postigo Alejandro, Serrano José Luis, Sierra Teresa, Hernández-Ainsa Silvia, Fernàndez-Busquets Xavier
Instituto de Nanociencia y Materiales de Aragón (INMA), Departamento de Química Orgánica-Facultad de Ciencias, CSIC-Universidad de Zaragoza, Zaragoza 50009, Spain.
Nanomalaria Group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, Barcelona 08028, Spain.
ACS Appl Polym Mater. 2022 Dec 30;5(1):381-390. doi: 10.1021/acsapm.2c01553. eCollection 2023 Jan 13.
The rampant evolution of resistance in to all existing antimalarial drugs calls for the development of improved therapeutic compounds and of adequate targeted delivery strategies for them. Loading antimalarials in nanocarriers specifically targeted to the parasite will contribute to the administration of lower overall doses, with reduced side effects for the patient, and of higher local amounts to parasitized cells for an increased lethality toward the pathogen. Here, we report the development of dendronized hyperbranched polymers (DHPs), with capacity for antimalarial loading, that are coated with heparin for their specific targeting to red blood cells parasitized by . The resulting DHP-heparin complexes exhibit the intrinsic antimalarial activity of heparin, with an IC50 of 400 nM, added to its specific targeting to -infected ( noninfected) erythrocytes. DHP-heparin nanocarriers represent a potentially interesting contribution to the limited family of structures described so far for the loading and targeted delivery of current and future antimalarial compounds.
疟原虫对所有现有抗疟药物的耐药性迅速演变,这就需要研发出改良的治疗性化合物以及针对这些化合物的适当靶向递送策略。将抗疟药物负载于专门靶向疟原虫的纳米载体中,有助于降低总体给药剂量,减少患者的副作用,并向被寄生细胞递送更高的局部剂量,从而提高对病原体的致死率。在此,我们报告了一种具有抗疟药物负载能力的树枝状超支化聚合物(DHP)的研发,该聚合物用肝素包被,以特异性靶向被疟原虫寄生的红细胞。所得的DHP-肝素复合物展现出肝素的内在抗疟活性,其IC50为400 nM,此外还具有对被疟原虫感染(而非未感染)红细胞的特异性靶向作用。DHP-肝素纳米载体为目前和未来抗疟化合物的负载和靶向递送,对迄今为止所描述的有限结构家族做出了潜在的有趣贡献。